InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ABEONA THERAPEUTICS INC.

ABEO Clue Score64
United States Fiscal year ends December CIK 0000318306 Results filed 13 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

18
Insider
Date
Role
Action
Shares
Price
Amount
Leila Alland
16 May 2024
Director
Buy
11,000
$4.71
$51.80K
Faith L. Charles
26 Apr 2024
Director
Buy
7,550
$3.28
$24.76K
Joseph Walter Vazzano
25 Apr 2024
Chief Financial Officer
Buy
5,608
$3.14
$17.61K
Brendan M. O'Malley
25 Apr 2024
SVP, General Counsel
Buy
8,600
$3.24
$27.86K
Vishwas Seshadri
25 Apr 2024
Chief Executive Officer
Buy
10,000
$3.20
$32.00K
Vishwas Seshadri
6 Feb 2024
Chief Executive Officer
Buy
20,000
$4.39
$87.80K
Vishwas Seshadri
27 Sep 2023
Chief Executive Officer
Buy
20,000
$4.07
$81.40K
Joseph Walter Vazzano
19 Sep 2023
Chief Financial Officer
Buy
2,986
$3.82
$11.41K
Joseph Walter Vazzano
19 Sep 2023
Chief Financial Officer
Buy
14
$3.70
$51.80
Brendan M. O'Malley
18 Sep 2023
SVP, General Counsel
Buy
3,000
$3.80
$11.40K
Brendan M. O'Malley
9 Dec 2022
SVP, General Counsel
Buy
5,869
$3.13
$18.37K
Brendan M. O'Malley
18 Nov 2022
SVP, General Counsel
Buy
7,500
$3.99
$29.93K
Joseph Walter Vazzano
18 Nov 2022
Chief Financial Officer
Buy
2,500
$4.00
$10.00K
Stefano Buono
24 Dec 2019
Director
Buy
200,000
$2.50
$500.00K
Stefano Buono
11 Apr 2019
Director
Buy
49,020
$7.91
$387.98K
Stefano Buono
10 Apr 2019
Director
Buy
20,980
$7.54
$158.27K
Stephen B. Howell
8 Apr 2019
Director
Buy
4,000
$7.77
$31.08K
Duyne Richard B Van
8 Apr 2019
Director
Buy
6,000
$7.71
$46.26K
Show all 132 transactions →

What was left out

Form 4 filings counted 284
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 10
Sales straight out of an exercise 3
Sales at will 100
Transactions with no price 0
Shares from compensation/vesting 10,551,935
Sales filed before the plan box existed 36
History held since 26 Oct 2006